[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.87.114.118. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1981

Epidermolysis Bullosa Acquisita

Arch Dermatol. 1981;117(7):383. doi:10.1001/archderm.1981.01650070011010
Abstract

Application of newly developed or refined laboratory techniques to a variety of diseases has often resulted in modification of time-honored clinical classifications. In the blistering diseases, the techniques of immunopathologic study and electron microscopy have provided the basis for more accurate diagnoses and more rational speculations on pathomechanisms. However, these accomplishments in no way relieve the investigator from the obligation to make careful clinical pathologic correlations to be certain that the new observations advance rather than retard our understanding of the diseases under study.

Epidermolysis bullosa acquisita (EBA) has been long established as a clinical entity, because its distinct clinical features are similar to those of inherited dermolytic epidermolysis bullosa. It is manifested by blisters that develop at sites of trauma, scarring, milia, oral mucous membrane lesions, and dystrophic nail changes. The only unique clinical features of EBA are the lack of inheritance and the appearance of the first lesions

First Page Preview View Large
First page PDF preview
First page PDF preview
×